Thank you for your interest in viewing the Update on ALS TDI Drug Development Pipeline webinar! Please join us on June 14, 2012 at 6:00 PM - 6:00 PM EDT
We will provide a comprehensive review of our current drug development pipeline, including the latest information on:
TDI 846 (Biogen Idec and UCB Pharma effort)
TDI 132 (clinical trial on Gilenya in ALS patients)
TDP43 mouse model charectorization
Steve Perrin, Ph.D.
John Lincecum, Ph.D.
Fernando G. Vieira, M.D.
Visit us in Cambridge, MA
Can't Make it to the Lab?
We would still love to share our lab with you. Learn more about our machines, space, and research online.